At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Board of Directors

Board of Directors

John F. Crowley
Chairman & Chief Executive Officer
Donald J. Hayden , Jr.
Lead Independent Director
Sol J. Barer Ph.D.
Chief Executive Officer, Celgene Corporation
James Barrett Ph.D.
General Partner, New Enterprise Associates
Mr. Robert Essner
Senior Advisor, The Carlyle Group
Ted W. Love M.D.
Executive Vice President, Head of Research & Development & Technical Operations, Onyx Pharmaceuticals
Margaret G. McGlynn R.Ph.
President & Chief Executive Officer, International AIDS Vaccine Initiative
Michael G. Raab
Chief Executive Officer and Chairman, Ardelyx
Glenn Sblendorio
President & Chief Financial Officer, The Medicines Company
James N. Topper M.D., Ph.D.
General Partner, Frazier Healthcare

Copyright © 2014 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy